Christin Glorioso
Founder and CEO at NeuroAge Therapeutics and Founder and Executive Director at Longevity SF
Physician-scientist and serial entrepreneur with expertise in neuroscience and computational modeling. I have more than 15 years of research experience focused on aging clocks in human brain, which forms the basis of my longevity techbio company, NeuroAge Therapeutics. NeuroAge is a finalist in the US National Institute of Aging Startup Challenge and recipient of the Illumina sequencing grant. I am passionate community building and am the Founder and Executive Director of Longevity SF, which connects longevity researchers, investors, and entrepreneurs in the SF Bay Area and in NYC. I was previously Chief Strategist of the Bakar Aging Research Institute at UCSF, Community Building Chair of the MIT Postdoc Association, and Graduate Student Body President.
Visit website: https://drglorioso.substack.com/about
christin-glorioso-md-phd-39627719
See also
NeuroAge Therapeutics
Longevity pharmatech that creates drugs to rejuvenate biological brain aging and treat neurodegenerative disorders
Details last updated 27-Dec-2022
Christin Glorioso is also referenced in the following:
Aging Code Summit
11-Jun-2025
Summit exploring the Aging Code through AI organised by Longevity Global (Cambridge, MA, USA)
Brain Aging & Alzheimer’s Prevention: The Future of Cognitive Health Testing
Optispan Podcast Episode-Brain Ageing & Alzheimer’s Prevention with Dr. Christin Glorioso
D.C. Summit 2025
28-Apr-2025
The Second Annual Alliance for Longevity Initiatives summit (Washington, D.C., USA)
The Longevity Summit 2024
03-Dec-2024 to 04-Dec-2024
Longevity researchers, investors, and entrepreneurs speaking about eliminating disease of ageing by Longevity Global (Novato, CA, USA)